Tenaya Therapeutics, Inc.
TNYA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001858848
In the last 90 days, Tenaya Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 101 institutions reported holding it in 13F filings for Q2 2026, worth $39.7M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Tenaya Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 101
- −1 vs. Q1 2026
- Shares held
- 53.7M
- −571.3K (−1.1%) vs. Q1 2026
- Total value
- $39.7M
- +$2.21M (+5.9%) vs. Q1 2026
- New holders
- 18
- 31 more added
- Sold out
- 19
- 17 more reduced
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TNYA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 101 | $39.7M |
| Q1 2026 | 103 | $37.5M |
| Q4 2025 | 98 | $48.8M |
| Q3 2025 | 91 | $55.6M |
| Q2 2025 | 89 | $19.3M |
| Q1 2025 | 107 | $27.7M |
| Q4 2024 | 88 | $62.8M |
| Q3 2024 | 95 | $111.2M |
| Q2 2024 | 96 | $177.0M |
| Q1 2024 | 90 | $292.9M |
| Q4 2023 | 74 | $151.4M |
| Q3 2023 | 77 | $126.8M |
| Q2 2023 | 79 | $279.7M |
| Q1 2023 | 65 | $128.3M |
| Q4 2022 | 68 | $94.7M |
| Q3 2022 | 73 | $102.2M |
| Q2 2022 | 50 | $208.6M |
| Q1 2022 | 50 | $439.9M |
| Q4 2021 | 47 | $667.6M |
| Q3 2021 | 47 | $693.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Tenaya Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Caitong International Asset Management Co., Ltd | 1 | $1 | 0.00% | +1 | New |
| Kalehua Capital Management LLC | 0 | $0 | 0.00% | −2,000,000−100.0% | Sold out |
| Alphabet Inc. | 0 | $0 | 0.00% | −915,705−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −207,100−100.0% | Sold out |
| Castleview Partners, LLC | 0 | $0 | 0.00% | −153,137−100.0% | Sold out |
| CI Private Wealth, LLC | 0 | $0 | 0.00% | −144,300−100.0% | Sold out |
| Redhawk Wealth Advisors, Inc. | 0 | $0 | 0.00% | −65,350−100.0% | Sold out |
| Nine Masts Capital Ltd | 0 | $0 | 0.00% | −51,344−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Rezny Wealth Management, Inc. | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −37,509−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −33,200−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −22,961−100.0% | Sold out |
| Arkadios Wealth Advisors | 0 | $0 | 0.00% | −17,253−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −16,327−100.0% | Sold out |
| Pasadena Private Wealth, LLC | 0 | $0 | 0.00% | −15,099−100.0% | Sold out |
| Legacy Wealth Partners, LLC | 0 | $0 | 0.00% | −14,084−100.0% | Sold out |
| Jasper Ridge Partners, L.P. | 0 | $0 | 0.00% | −10,250−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −7,558−100.0% | Sold out |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −616−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |